Family History of Type 2 Diabetes and Its Association with Beta Cell Function and Lipid Profile in Newly Diagnosed Pediatric Patients with Type 1 Diabetes

References

• Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. Feb, 2014;103(2):137–149. doi:10.1016/j.diabres.2013.11.002.
   PubMed Web of Science ®Google Scholar
• Tuomilehto J. The emerging global epidemic of type 1 diabetes. Curr Diab Rep. 2013 Dec;13(6):795–804. doi:10.1007/s11892-013-0433-5.
   PubMed Web of Science ®Google Scholar
• Divers J, Mayer-Davis EJ, Lawrence JM, et al. Trends in incidence of type 1 and type 2 diabetes among youths - selected counties and Indian reservations, United States, 2002-2015. Morb Mortal Wkly Rep. Feb 14 2020;69(6):161–165. doi:10.15585/mmwr.mm6906a3.
   PubMed Web of Science ®Google Scholar
• Weng J, Zhou Z, Guo L, et al. Incidence of type 1 diabetes in China, 2010-13: population based study. BMJ. Jan 3 2018;360:j5295. doi10.1136/bmj.j5295.
   PubMedGoogle Scholar
• DiMeglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. Lancet. Jun 16 2018;391(10138):2449–2462. doi: 10.1016/s0140-6736(18)31320-5.
   PubMed Web of Science ®Google Scholar
• Redondo MJ, Evans-Molina C, Steck AK, Atkinson MA, Sosenko J. The influence of type 2 diabetes-associated factors on type 1 diabetes. Diab Care. Aug, 2019;42(8):1357–1364. doi:10.2337/dc19-0102.
   PubMed Web of Science ®Google Scholar
• Liston A, Todd JA, Lagou V. Beta-cell fragility as a common underlying risk factor in type 1 and type 2 diabetes. Trends Mol Med. Feb, 2017;23(2):181–194. doi:10.1016/j.molmed.2016.12.005.
   PubMed Web of Science ®Google Scholar
• Marroqui L, Dos Santos RS, Op de Beeck A, et al. Interferon-α mediates human beta cell HLA class I overexpression, endoplasmic reticulum stress and apoptosis, three hallmarks of early human type 1 diabetes. Diabetologia. 2017, Apr;60(4):656–667. doi:10.1007/s00125-016-4201-3.
   PubMed Web of Science ®Google Scholar
• Redondo MJ, Steck AK, Sosenko J, et al. Transcription factor 7-like 2 (tcf7l2) gene polymorphism and progression from single to multiple autoantibody positivity in individuals at risk for type 1 diabetes. Diab Care. 2018, Dec;41(12):2480–2486. doi:10.2337/dc18-0861.
   PubMed Web of Science ®Google Scholar
• Redondo MJ, Muniz J, Rodriguez LM, et al. Association of TCF7L2 variation with single islet autoantibody expression in children with type 1 diabetes. BMJ Open Diabetes Res Care. 2014;2(1):e000008. doi:10.1136/bmjdrc-2013-000008.
   PubMedGoogle Scholar
• Thorn LM, Forsblom C, Wadén J, et al. Effect of parental type 2 diabetes on offspring with type 1 diabetes. Diab Care. Jan, 2009;32(1):63–68. doi:10.2337/dc08-0472.
   PubMed Web of Science ®Google Scholar
• Purnell JQ, Dev RK, Steffes MW, et al. Relationship of family history of type 2 diabetes, hypoglycemia, and autoantibodies to weight gain and lipids with intensive and conventional therapy in the diabetes control and complications trial. Diabetes. 2003, Oct;52(10):2623–2629. doi:10.2337/diabetes.52.10.2623.
   PubMed Web of Science ®Google Scholar
• Standards of medical care in diabetes–2011. Diab Care. Jan, 2011;34(Suppl 1):S11–61. doi:10.2337/dc11-S011.
   PubMed Web of Science ®Google Scholar
• Peng W, Yuan J, Chiavaroli V, et al. 10-yEar incidence of diabetic ketoacidosis at type 1 diabetes diagnosis in children aged less than 16 years from a large regional center (Hangzhou, China). Front Endocrinol (Lausanne). 2021;12:653519. doi:10.3389/fendo.2021.653519.
   PubMed Web of Science ®Google Scholar
• Barlow SE. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics. 2007 Dec;120(Suppl 4):S164–92. doi:10.1542/peds.2007-2329C.
   PubMed Web of Science ®Google Scholar
• Julieana NM. MPH. Normal growth patterns in infants and prepubertal children. Updated September 09, 2022. https://www.uptodate.cn/contents/normal-growth-patterns-in-infants-and-prepubertal-children Accessed March 15 2023.
   Google Scholar
• Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. Dec, 2011;128(Suppl 5):S213–56. doi:10.1542/peds.2009-2107C.
   PubMedGoogle Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. Jul, 1985;28(7):412–419. doi:10.1007/bf00280883.
   PubMed Web of Science ®Google Scholar
• Chen Y, Xie Y, Xia Y, et al. Prevalence, clinical characteristics and HLA genotypes of idiopathic type 1 diabetes: A cross-sectional study. Diabetes Metab Res Rev. Sep, 2023;39(6):e3676. doi:10.1002/dmrr.3676.
   PubMed Web of Science ®Google Scholar
• Zhu M, Li Y, Dong G, et al. Prevalence and phenotypic features of diabetes due to recessive, non-syndromic WFS1 mutations. Eur J Endocrinol. Dec 10 2021;186(2):163–170. doi:10.1530/eje-21-0097.
   PubMed Web of Science ®Google Scholar
• Parkkola A, Turtinen M, Härkönen T, Ilonen J, Knip M. Family history of type 2 diabetes and characteristics of children with newly diagnosed type 1 diabetes. Diabetologia. 2021 Mar;64(3):581–590. doi:10.1007/s00125-020-05342-x.
   PubMed Web of Science ®Google Scholar
• Wang Q, Chen Y, Xie Y, et al. Type 2 diabetes family history as a significant index on the clinical heterogeneity differentiation in type 1 diabetes. J Clin Endocrinol Metab. Jun 15, 2023;108(12):e1633–e1641. doi:10.1210/clinem/dgad363.
   PubMed Web of Science ®Google Scholar
• Chen Y, Wang Q, Xie Z, et al. The impact of family history of type 2 diabetes on clinical heterogeneity in idiopathic type 1 diabetes. Diabetes Obes Metab. Feb, 2023;25(2):417–425. doi:10.1111/dom.14884.
   PubMed Web of Science ®Google Scholar
• Mishra R, Hodge KM, Cousminer DL, et al. A gLobal perspective of latent autoimmune diabetes in adults. Trends Endocrinol Metab. Sep, 2018;29(9):638–650. doi:10.1016/j.tem.2018.07.001.
   PubMed Web of Science ®Google Scholar
• Buzzetti R, Maddaloni E, Gaglia J, et al. Adult-onset autoimmune diabetes. Nat Rev Dis Primers. Sep 2022; 22;8(1):64. doi:10.1038/s41572-022-00390-6.
   PubMedGoogle Scholar
• Felton JL, Cuthbertson D, Warnock M, et al. Type 1 diabetes TrialNet study group. HOMA2-B enhances assessment of type 1 diabetes risk among TrialNet pathway to prevention participants. Diabetologia. 2022 Jan;65(1):88–100. doi:10.1007/s00125-021-05573-6.
   PubMed Web of Science ®Google Scholar
• Femlak M, Gluba-Brzózka A, Ciałkowska-Rysz A, Rysz J. The role and function of HDL in patients with diabetes mellitus and the related cardiovascular risk. Lipids Health Dis. Oct 30 2007;16(1):207. doi:10.1186/s12944-017-0594-3.
   PubMedGoogle Scholar
• Chen L, Zhao Y, Wang Z, et al. Very high HDL-C (high-density lipoprotein cholesterol) is associated with increased cardiovascular risk in patients with NSTEMI (non-ST-segment elevation myocardial infarction) undergoing PCI (percutaneous coronary intervention). BMC Cardiovasc Disord. Jul 17 2023;23(1):357. doi:10.1186/s12872-023-03383-9.
   PubMed Web of Science ®Google Scholar
• Lin CH, Lo FS, Huang YY, et al. Evaluation of dIsease complications among adults with type 1 diabetes and a family history of type 2 diabetes in Taiwan. JAMA Netw Open. Dec 1 2021;4(12):e2138775. doi:10.1001/jamanetworkopen.2021.38775.
   PubMed Web of Science ®Google Scholar
• Jacobsen LM, Vehik K, Veijola R, et al. Heterogeneity of DKA incidence and age-specific clinical characteristics in children diagnosed with type 1 diabetes in the teddy study. Diab Care. Mar 1 2022;45(3):624–633. doi:10.2337/dc21-0422.
   PubMed Web of Science ®Google Scholar
• Bureau HS. Hangzhou statistical yearbook 2021. Updated November 15 2021. https://zjjcmspublic.oss-cn-hangzhou-zwynet-d01-a.internet.cloud.zj.gov.cn/jcms_files/jcms1/web3148/site/attach/0/e178e5878881430b8634e83f2a5a9197.pdf. Accessed March 15 2023.
   Google Scholar
• Hattersley AT, Greeley SAW, Polak M, et al. ISPAD clinical practice consensus guidelines 2018: The diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes. Oct, 2018;19(Suppl 27):47–63. doi:10.1111/pedi.12772.
   PubMed Web of Science ®Google Scholar
• Delvecchio M, Mozzillo E, Salzano G, et al. Monogenic diabetes accounts for 6.3% of cases referred to 15 Italian pediatric diabetes centers during 2007 to 2012. J Clin Endocrinol Metab. Jun 1 2017;102(6):1826–1834. doi:10.1210/jc.2016-2490.
   PubMed Web of Science ®Google Scholar
• Pihoker C, Gilliam LK, Ellard S, et al. Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for diabetes in youth. J Clin Endocrinol Metab. Oct, 2013;98(10):4055–4062. doi:10.1210/jc.2013-1279.
   PubMed Web of Science ®Google Scholar
• Shepherd M, Shields B, Hammersley S, et al. Systematic population screening, using biomarkers and genetic testing, identifies 2.5% of the U.K. pediatric diabetes population with monogenic diabetes. Diab Care. 2016, Nov;39(11):1879–1888. doi:10.2337/dc16-0645.
   PubMed Web of Science ®Google Scholar